Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Glaxosmithkline Plc

(NYSE: GSK)
Add to Portfolio
+0.06 (+0.14%)
as of Oct 18, 2019

Last 42.53
Change +0.06 (+0.14%)
Open 42.52
Prev. Close 42.47
Today's Range
42.37
42.64
52wk Range
36.41
43.22
Volume 1,428,100
Avg Volume 2,282,725
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
GSK +0.14% +5.01% +7.37%
DJIA -0.95% +1.49% +5.48%
S&P 500 -0.39% +1.64% +7.85%

Key Statistics

Annual EPS 2.23
Dividend Yield 4.34%
P/E Ratio 13.25
Market Capitalization, $K 105,455,273
Weighted Alpha +6.60
Standard Deviation +0.15
Profit Margin 11.93%
Beta 0.68

Growth Rates

YTD +11.31%
1-Year +4.06%
3-Year +3.40%
5-Year -7.12%
10-Year +3.33%

Opinion

Sell Hold Buy

Recent Headlines

Digestive Remedies Market is anticipated to reach the

GlobeNewswire via COMTEX - Mon Oct 07, 09:30AM EDT
According to a recently published PMR report, global digestive remedies market in 2018 exceeded US$ 15 Bn and is expected to grow at a moderate CAGR during the forecast period. Digestive remedies such as probiotics are used for th(full story)
GSK: 42.53 (+0.06), JNJ: 127.70 (-8.47), PG: 117.47 (+0.84)

Patients Demand Personalized Treatments for Cancer as

PR Newswire via COMTEX - Thu Oct 03, 09:00AM EDT
Cancer is ranked among the top causes of death globally, and recent data indicates that the number of cancer related cases is only expected to rise. As a result, the global cancer therapeutics market is projected to grow. Accordin(full story)
QBIO: 0.4300 (-0.0442), ABBV: 76.46 (+1.32), SGEN: 87.40 (+1.46), MRK: 84.68 (+0.88), GSK: 42.53 (+0.06)

GSK Submits Filing to FDA for Trelegy Ellipta Use in

BusinessWire via COMTEX - Wed Oct 02, 09:08AM EDT
GlaxoSmithKline plc (GSK) and Innoviva, Inc. (INVA) today announced the filing of a supplemental New Drug Application (sNDA) to the US Food and Drug Administration (FDA) seeking an additional indication for the use of once-daily, (full story)
GSK: 42.53 (+0.06)

Healthcare Companies Seek Innovative Ways to Combat

PR Newswire via COMTEX - Tue Oct 01, 09:00AM EDT
Many underdeveloped regions around the world are ravaged by diseases due to their lack of proper healthcare. And despite ongoing medical advancements, researchers have noted that new diseases are continuing to emerge. The Institut(full story)
GSK: 42.53 (+0.06), INMB: 4.35 (+0.13), LLY: 108.64 (+0.18), BMY: 53.03 (+0.61), AZN: 43.87 (-0.26)

Thermo Fisher Scientific Completes Acquisition of GSK

PR Newswire via COMTEX - Tue Oct 01, 06:00AM EDT
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has completed its previously announced acquisition of an active pharmaceutical ingredient (API) manufacturing facility from GlaxoSmithKline (GSK) for (full story)
GSK: 42.53 (+0.06), TMO: 281.42 (-0.17)